Regulation of redox signalling and autophagy during cardiovascular diseases-role of resveratrol

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 8, 2015, Pages 1530-1536

  Fu, D G ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Autophagy; Cardiac disorders; Reactive oxygen species (ROS); Redox; Resveratrol; Signalling

Indexed keywords

REACTIVE OXYGEN METABOLITE; RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ARTICLE; AUTOPHAGY; CARDIOVASCULAR DISEASE; DRUG MECHANISM; HEART PROTECTION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION; ANIMAL; CARDIOVASCULAR DISEASES; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; AUTOPHAGY; CARDIOVASCULAR DISEASES; HUMANS; OXIDATION-REDUCTION; STILBENES;

EID: 84942237867     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. NONOMURA S, KANAGAWA H, MAKIMOTO A. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jokon (Polygonum Cuspidatum SIEB et ZUCC). Yakugaku Zasshi 1963; 83: 983-988.
2. JANG M, CAI L, UDEANI GO, SLOWING KV, THOMAS CF, BEECHER CW, FONG HH, FARNSWORTH NR, KINGHORN AD, MEHTA RG, MOON RC, PEZZUTO JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220.
3. SIEMANN EH, CREASY LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43: 49-52.
4. ALAGAWANY MM, FARAG MR, DHAMA K, ABD EL-HACK ME, TIWARI R, ALAM GM. Mechanisms and beneficial applications of resveratrol as feed additive in animal and poultry nutrition: a review. Int J Pharmacol 2015; 11: 213-221.
5. RICCIONI G, MANCINI B, DI ILIO E, BUCCIARELLI T, D'ORAZIO N. Protective effect of lycopene in cardiovascular disease. Eur Rev Med Pharmacol Sci 2008; 12: 183-190.
6. IANNITTI T, PALMIERI B. Antioxidant therapy effectiveness: an up to date. Eur Rev Med Pharmacol Sci 2009; 13: 245-278.
7. TRACHOOTHAM D, LU W, OGASAWARA MA, NILSA RD, HUANG P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343-1374.
8. CAI H, GARRISON DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87: 840-844.
9. BUYUKLU M, KANDEMIR FM, OZKARACA M, SET T, BAKIRCI EM, TOPAL E. Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis? Eur Rev Med Pharmacol Sci 2014; 18: 461-470.
10. GUSTAFSSON AB, GOTTLIEB RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 2008; 44: 654-661.
11. DE DC, WATTIAUX R. Functions of lysosomes. Ann Rev Physiol 1966; 28: 435-492.
12. KUMA A, HATANO M, MATSUI M, YAMAMOTO A, NAKAYA H, YOSHIMORI T. The role of autophagy during the early neonatal starvation period. Nature 2004; 432: 1032-1036.
13. GURUSAMY N, MUKHERJEE S, LEKLI I, BEARZI C, BARDELLI S, DAS DK. Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells. Antioxid Redox Signal 2009; 11: 589-600.
14. ANAND-SRIVASTAVA MB. Modulation of Gi protein in hypertension: role of angiotensin II and oxidative stress. Curr Cardiol Rev 2010; 6: 298-308.
15. CHAN V, FENNING A, IYER A, HOEY A, BROWN L. Resveratrol improves cardiovascular function in DOCA-salt hyper tensive rats. Curr Pharm Biotechnol 2011; 12: 429-436.
16. GOSWAMI SK, DAS DK. Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts. Curr Cardiol Rev 2010; 6: 265-273.
17. DAS DK, MAULIK N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 2006; 6: 36-47.
18. DAS S, CORDIS GA, MAULIK N, DAS DK. Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 2005; 288: H328-H335.
19. GURUSAMY N, LEKLI I, MUKHERJEE S, RAY D, AHSAN MK, GHERGHICEANU M, POPESCU LM, DAS DK. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res 2010; 86: 103-112.
20. TALALAY P, DINKOVA-KOSTOVA AT, HOLTZCLAW WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 2003; 43: 121-134.
21. CHEN CY, JANG JH, LI MH, SURH YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005; 331: 993-1000.
22. KANTOR PF, LUCIEN A, KOZAK R, LOPASCHUK GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3- ketoacyl coenzyme A thiolase. Circ Res 2000; 86: 580-588.
23. KODDE IF, VAN DER STOK J, SMOLENSKI RT, DE JONG JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A Mol Integr Physiol 2007; 146: 26-39.
24. ASHRAFIAN H, FRENNEAUX MP, OPIE LH. Metabolic mechanisms in heart failure. Circulation 2007; 116: 434-448.
25. Lam A, Lopaschuk GD. Anti-anginal effects of partial fatty acid oxidation inhibitors. Curr Opin Pharmacol 2007; 7: 179-185.
26. LEBER B, LIN J, ANDREWS DW. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 2007; 12: 897-911.
27. KATO H, TAKAHASHI S, TAKENAKA A, FUNABIKI R, NOGUCHI T, NAITO H. Degradation of endogenous proteins and internalized asialofetuin in primary cultured hepatocytes of rats. Int J Biochem 1989; 21: 483-495.
28. TERMAN A, BRUNK UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005; 68: 355-365.
29. KURZ T, TERMAN A, BRUNK UT. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophys 2007; 462: 220-230.
30. ZHU H, TANNOUS P, JOHNSTONE JL, KONG Y, SHELTON JM, RICHARDSON JA, LE V, LEVINE B, ROTHERMEL BA, HILL JA. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117: 1782-1793.
31. CASPER RF, QUESNE M, ROGERS IM, SHIROTA T, JOLIVET A, MILGROM E, SAVOURET JF. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol Pharmacol 1999; 56: 784-790.
32. JANG M, CAI L, UDEANI GO, SLOWING KV, THOMAS CF, BEECHER CW, FONG HHS, FARNSWORTH NR, KINGHORN DA, MEHTA RG, MOON RC, PEZZUTO JM. Cancer chemorprevention activity of resveratrol, a nature product derived from grapes. Science 1997; 275: 218-220.
33. MACCARRONE M, LORENZON T, GUERRIERI P, AGRÒ AF. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999; 265: 27-23.
34. SUBBARAMAIAH K, CHUNG WJ, DANNENBERG AJ. Ceramide regulates the transcription of cyclooxygenase- 2. Evidence for involvement of ERK/JNK and p38 pathways. J Biol Chem1998; 273: 32943-32949.
35. HOLMES MM, BALDWIN AS. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000; 60: 3477-3483.
36. SURH YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Can 2003; 3: 768-780.
37. GILMORE TD. Introduction of NFkB players, pathways and perspectives. Oncogene 2006; 25: 6680-6684.
38. PERKINS ND. Integrating cell signaling pathways with NFkB and IKK function. Nat Rev Mol Cell Boil 2007; 8: 49-62.
39. BRASIER AR. The NF-kB regulatory network. Cardivasc Toxicol 2006; 6: 111-130.
40. CHEN CY, JANG JH, LI MH, SURH YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005; 331: 993-1000.
41. KIM DW, SOVAK MA, ZANIESKI G, NONET G, ROMIEUMOUREZ R, LAU AW, HAFER LJ, YASWEN P, STAMPFER M, ROGERS AE, RUSSO J, SONENSHEIN GE. Activation of NFkB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 2000; 21: 871-879.
42. BHARTI AC, DONATO N, AGGARWAL BB. Curcumin (diferuloyl methane) inhibits constitutive and IL- 6 inducible STAT3 phosphorylation in multiple myeloma cells. J Immunol 2003; 171: 3863-3871.
43. EFERL R, WAGNER EF. AP-1: a double edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-868.
44. PORAT Y, ABRAMOWITZ A, GAZIT E. Inhibition of amyloid fibril formation by polyphenols:structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 2006; 67: 27-37.
45. DONMEZ G, WANG D, COHEN DE, GUARENTE L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010; 142: 320-332.
46. LIU T, BITAN G. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases:strategies and mechanisms. Chem Med Chem 2012; 7: 359-374.
47. GOMES AP, PRICE NL, LING AJ, MOSLEHI JJ, MONTGOMERY MK, RAJMAN L, WHITE JP, TEODORO JS, WRANN CD, HUBBARD BP, MERCKEN EM, PALMEIRA CM, DE CABO R, ROLO AP, TURNER N, BELL EL, SINCLAIR DA. Declining NAD(+) induces a pseudo hypoxic state disrupting nuclear mitochondrial communication during aging. Cell 2013; 155: 1624-1638.
48. LEONARD SS, XIA C, JIANG BH, STINEFELT B, KLANDORF H, HARRIS GK, SHI X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 2003; 309: 1017-1026.
49. CHOI KM, LEE HL, KWON YY, KANG MS, LEE SK, LEE CK. Enhancement of mitochondrial function correlates with the extension of lifespan by caloric restriction and caloric restriction mimetics in yeast. Biochem Biophys Res Commun 2013; 441: 236-242.
50. CHEN ML, YI L, JIN X, LIANG XY, ZHOU Y, ZHANG T, XIE Q, ZHOU X, CHANG H, FU YJ, ZHU JD, ZHANG QY, MI MT. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy 2013; 9: 2033-2045.
51. YE J, LIU Z, WEI J, LU L, HUANG Y, LUO L, XIE H. Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via thep53-caspase-3-dependent apoptotic pathway. Neurosci Lett 2013; 553: 72-77.